Medicare Enrolled
Dr. Bao Dao, MD
Hematology & Oncology · Dublin, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dao from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dao?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dao
Dr. Bao Dao is a hematology & oncology specialist in Dublin, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Dao performed 53,967 Medicare services across 2,221 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dao received a total of $31,525 from 104 pharmaceutical and/or device companies across 1408 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dao is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 14% volume in CA
$31,525 industry payments
Medicare Practice Summary
Medicare Utilization ↗53,967
Medicare services
Top 14% in CA for hematology & oncology
2,221
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,373 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 17,820 | $18 | $65 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
6,000 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 5,850 | $1 | $9 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
5,453 | $2 | $21 |
| Injection, granisetron, extended-release, 0.1 mg | 4,300 | $5 | $20 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,770 | $6 | $29 |
| MRI contrast dye injection (gadobutrol) | 1,940 | $0 | $2 |
| Iron infusion (Monoferric) | 1,700 | $17 | $71 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,470 | $0 | $7 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,243 | $8 | $32 |
| Anti-nausea injection (Aloxi/palonosetron) | 770 | $1 | $101 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
745 | $8 | $17 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
562 | $14 | $83 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
543 | $168 | $463 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
337 | $140 | $647 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
335 | $30 | $141 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
305 | $111 | $358 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
257 | $74 | $254 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
164 | $29 | $143 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
137 | $1 | $9 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 117 | $284 | $1,137 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
115 | $1,699 | $6,769 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
101 | $69 | $319 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
99 | $68 | $297 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
95 | $20 | $88 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
90 | $104 | $246 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
89 | $72 | $186 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
80 | $83 | $362 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
69 | $154 | $499 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
66 | $26 | $110 |
| New patient office visit, complex (60-74 min) | 59 | $197 | $610 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
53 | $178 | $931 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
53 | $6 | $431 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
48 | $1 | $32 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
42 | $51 | $259 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
38 | $303 | $1,380 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
18 | $125 | $770 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
17 | $35 | $242 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
17 | $135 | $466 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.0% high complexity
88.0% medium
7.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$31,525
Total received (2018-2024)
Avg $4,504/year across 7 years
Top 15% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
104
Companies
1,408
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$27,666 (87.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,332 (10.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$527 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,974
2023
$5,395
2022
$4,540
2021
$4,143
2020
$3,128
2019
$4,363
2018
$3,981
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$540
PFIZER INC.
$464
Novartis Pharmaceuticals Corporation
$428
Merck Sharp & Dohme LLC
$369
Takeda Pharmaceuticals U.S.A., Inc.
$339
E.R. Squibb & Sons, L.L.C.
$307
Janssen Biotech, Inc.
$288
Eisai Inc.
$250
Celgene Corporation
$241
Coherus Biosciences Inc.
$163
Regeneron Healthcare Solutions, Inc.
$158
Genentech USA, Inc.
$153
Stemline Therapeutics Inc.
$136
JAZZ PHARMACEUTICALS INC.
$117
ARRAY BIOPHARMA INC
$115
ABBVIE INC.
$103
Gilead Sciences, Inc.
$101
Boehringer Ingelheim Pharmaceuticals, Inc.
$94
Daiichi Sankyo Inc.
$90
Incyte Corporation
$90
Rigel Pharmaceuticals, Inc.
$83
Astellas Pharma US Inc
$83
Lilly USA, LLC
$77
Organon Llc
$66
ADC Therapeutics America, Inc.
$63
BeiGene USA, Inc.
$60
GlaxoSmithKline, LLC.
$59
TAIHO ONCOLOGY, INC.
$55
PUMA BIOTECHNOLOGY, INC.
$55
Bayer Healthcare Pharmaceuticals Inc.
$53
SOBI, INC
$53
Kyowa Kirin, Inc.
$51
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
Sumitomo Pharma America, Inc.
$43
SERVIER PHARMACEUTICALS LLC
$41
GENZYME CORPORATION
$35
SpringWorks Therapeutics, Inc.
$34
Octapharma USA, Inc.
$34
Karyopharm Therapeutics Inc.
$33
Alexion Pharmaceuticals, Inc.
$33
EMD Serono, Inc.
$32
Amgen Inc.
$32
Ipsen Biopharmaceuticals, Inc
$31
Geron Corporation
$30
Agios Pharmaceuticals, Inc.
$29
Aveo Pharmaceuticals, Inc.
$26
Amneal Pharmaceuticals LLC
$25
Apellis Pharmaceuticals, Inc.
$25
TerSera Therapeutics LLC
$24
Pharmacosmos Therapeutics Inc.
$21
Verity Pharmaceuticals Inc.
$20
Dendreon Pharmaceuticals LLC
$20
Fennec Pharmaceuticals, Inc.
$20
Azurity Pharmaceuticals, Inc.
$19
Kite Pharma, Inc.
$17
Top 3 companies account for 24.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$2,905
Heron Therapeutics, Inc.
$2,067
Novartis Pharmaceuticals Corporation
$2,059
AstraZeneca Pharmaceuticals LP
$1,627
PFIZER INC.
$1,476
Takeda Pharmaceuticals U.S.A., Inc.
$1,431
E.R. Squibb & Sons, L.L.C.
$1,418
Astellas Pharma US Inc
$1,184
Amgen Inc.
$1,102
Celgene Corporation
$1,077
Merck Sharp & Dohme LLC
$812
Lilly USA, LLC
$805
Seagen Inc.
$744
Merck Sharp & Dohme Corporation
$659
Eisai Inc.
$646
Genentech USA, Inc.
$640
GENZYME CORPORATION
$570
Kite Pharma, Inc.
$485
Incyte Corporation
$442
Pharmacyclics LLC, An AbbVie Company
$432
Daiichi Sankyo Inc.
$423
Boehringer Ingelheim Pharmaceuticals, Inc.
$382
Coherus Biosciences Inc.
$378
Stemline Therapeutics Inc.
$331
ADC Therapeutics America, Inc.
$288
ARRAY BIOPHARMA INC
$284
Gilead Sciences, Inc.
$284
Organon LLC
$264
Regeneron Healthcare Solutions, Inc.
$260
JAZZ PHARMACEUTICALS INC.
$233
Rigel Pharmaceuticals, Inc.
$226
Ipsen Biopharmaceuticals, Inc
$225
Aurobindo Pharma USA, Inc.
$216
Octapharma USA, Inc.
$216
Pharmacyclics LLC, an AbbVie Company
$210
Bayer HealthCare Pharmaceuticals Inc.
$200
BeiGene USA, Inc.
$198
Foundation Medicine, Inc.
$198
EISAI INC.
$171
Myovant Sciences Inc.
$161
GlaxoSmithKline, LLC.
$155
Lexicon Pharmaceuticals, Inc.
$149
Pharmacosmos Therapeutics Inc.
$134
Bayer Healthcare Pharmaceuticals Inc.
$130
Alexion Pharmaceuticals, Inc.
$129
PUMA BIOTECHNOLOGY, INC.
$126
EMD Serono, Inc.
$124
Exelixis Inc.
$123
Acrotech Biopharma LLC
$122
Jazz Pharmaceuticals Inc.
$121
Kyowa Kirin, Inc.
$113
Sobi, Inc
$109
Clovis Oncology, Inc.
$108
ABBVIE INC.
$103
Sumitomo Pharma America, Inc.
$102
Intuitive Surgical, Inc.
$97
TAIHO ONCOLOGY, INC.
$95
TerSera Therapeutics LLC
$88
Blueprint Medicines Corporation
$83
SOBI, INC
$78
Dendreon Pharmaceuticals LLC
$76
Puma Biotechnology, Inc.
$75
Tactile Systems Technology Inc
$69
Taiho Oncology, Inc.
$68
Organon Llc
$66
SERVIER PHARMACEUTICALS LLC
$65
Epizyme, Inc.,
$61
Global Blood Therapeutics, Inc.
$61
TESARO, Inc.
$53
Mirati Therapeutics, Inc.
$50
CTI BioPharma Corp.
$49
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
Karyopharm Therapeutics Inc.
$45
Janssen Pharmaceuticals, Inc
$45
MorphoSys, US Inc.
$42
Verastem, Inc.
$38
AMAG Pharmaceuticals, Inc.
$37
SpringWorks Therapeutics, Inc.
$34
PharmaEssentia USA Corporation
$30
Geron Corporation
$30
Agios Pharmaceuticals, Inc.
$29
Acrotech Biopharma Inc.
$28
MEDIVATION FIELD SOLUTIONS LLC
$27
AVEO Pharmaceuticals, Inc.
$26
Aveo Pharmaceuticals, Inc.
$26
Amneal Pharmaceuticals LLC
$25
Apellis Pharmaceuticals, Inc.
$25
Ferring Pharmaceuticals Inc.
$23
Dova Pharmaceuticals
$21
Verity Pharmaceuticals Inc.
$20
Fennec Pharmaceuticals, Inc.
$20
Azurity Pharmaceuticals, Inc.
$19
Servier Pharmaceuticals LLC
$18
Array BioPharma Inc.
$18
INSYS Therapeutics Inc
$17
Novo Nordisk Inc
$16
Sandoz Inc.
$16
ACCORD HEALTHCARE, INC.
$16
Advanced Accelerator Applications
$15
EUSA Pharma (US) LLC
$13
Grifols USA, LLC
$12
Seattle Genetics, Inc.
$12
Davol Inc.
$12
McKesson Specialty Care Distribution, LLC
$10
Top 3 companies account for 22.3% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · ANDEXXA · AVASTIN · AYVAKIT · Abraxane · Alecensa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DEFITELIO · DOPTELET · Da Vinci Surgical System · Doptelet · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Empaveli · Enhertu · FERAHEME · FIRMAGON · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Flexitouch Plus · Folotyn · GAVRETO · GAZYVA · GILOTRIF · Gamunex-C · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kerendia · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Marqibo · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONIVYDE · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PANZYGA · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Phasix · Pomalyst · Poteligeo · Prolia · REBLOZYL · RETEVMO · RYBELSUS · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNAGIS · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEPMETKO · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trelstar · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · VONJO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIEXTENZO · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
98
Per 100K population
5.9
County median income
$126,240
Nearest hospital
STANFORD HEALTH CARE TRI-VALLEY
5.7 mi
5.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dao is a mixed practice specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement in the top 15% of CA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dao experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Dao performed 17,820 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dao receive payments from pharmaceutical companies?
Yes. Dr. Dao received a total of $31,525 from 104 companies across 1,408 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dao's costs compare to other hematology & oncology specialists in Dublin?
Dr. Dao's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dao) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Dublin
Browse hematology & oncology specialists in Dublin ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Heron Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Heron Therapeutics, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology